VXRTVaxart Inc
0.0% today · −9.8% over a year
No score: too little data.
No dividend.
Vaxart Inc (VXRT) belongs to the Health care sector and is listed on OTC; country: United States. Its market value is about €80.6M. Over the past 12 months the price changed by −9.8%, with an annualised volatility of 88% and a largest fall of 54%.
Smart Score
How it is scored →Not scored: not enough data for a fair comparison.
Red flags and notes
- Caution. Negative free cash flow in at least two of the last three years. More in the glossary → Negative free cash flow in at least two of the last three years.
- Below $1 Price below one US dollar: not ranked against peers.
Price chart
Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.
Key metrics
Valuation
- P/E
- 3.1
- P/B
- 1.4
- P/S
- 0.5
- EV/EBIT
- 0.8
- Free-cash-flow yield
- 35.4%
- Market cap (EUR)
- €80.6M
Profitability and debt
- Return on equity
- 62.4%
- Return on invested capital
- 143.3%
- Net debt / EBITDA
- −1.85
Dividends
- Dividend yield
- 0.00%
- Payout ratio
- 0%
- Years without a lower dividend
- 0
Returns and risk
- 1 day
- 0.0%
- 1 month
- −14.0%
- 1 year
- −9.8%
- Volatility, 1 yr
- 88.1%
- Max drawdown, 1 yr
- −53.8%
- Beta
- 1.42
Ratios from SEC filings and end-of-day prices; returns are price changes without dividends.
Similar companies
Same sector and region, closest in market value.
| FRNMFreenome Inc. | —/10 | 0.0% | −1.2% |
|---|---|---|---|
| ATRAAtara Biotherapeutics Inc | —/10 | 0.0% | −30.7% |
| BDTXBlack Diamond Therapeutics Inc | —/10 | 0.0% | −52.2% |
| SKINSkinHealth Systems | 2/10 | 0.0% | −40.1% |
| AVXLAnavex Life Sciences Corp. | —/10 | 0.0% | −83.3% |
| HCATHealth Catalyst | 1/10 | 0.0% | −46.6% |
| HRTXHeron Therapeutics Inc | —/10 | 0.0% | −66.4% |
| CHRSCoherus Oncology | —/10 | 0.0% | −39.0% |
News and filings
- Vaxart, Inc.: 10-Q — Quarterly report for the period ending 30 Sep 2026
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 5 Nov 2026
- Vaxart, Inc.: 8-K — Results of operations
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 5 Nov 2026
- Vaxart, Inc.: 8-K — Director or officer change; Regulation FD disclosure
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 19 Oct 2026
- Vaxart, Inc.: 8-K — Other events
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 14 Sep 2026
- Vaxart, Inc.: 8-K — Other events
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 25 Aug 2026
What the marks mean
- FactA filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.
- Media reportA headline from a named media outlet. We link to it and do not check it.
- RumourUnconfirmed: the headline itself hedges (“reportedly”, “sources say”, “in talks”), names no publisher, or comes from a news aggregator or an automated republisher.
Source: Filings: U.S. SEC EDGAR. The tone is scored automatically from the headline and can be wrong.
Score changes in the last 12 months
Every published rating and change, logged when it was published (EU Market Abuse Regulation).
Show the log: 1 entry
| Date | Event | Balanced | Growth · Income | Warnings | Price at publication |
|---|---|---|---|---|---|
| First rating | —/10 | — · — | Available with Invest Pro |
Ratings are rules-based descriptions, valid until the next scoring run (about 06:20 and 21:50 UTC) and the same for every visitor.
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.